Moderna, largest biotech to go public, fails to impress in market debut

At that opening price, Moderna was valued at $7.32 billion, based on 332.9 million outstanding shares including over-allotment, making it the biggest biotech company to go public.

Original source: https://health.economictimes.indiatimes.com/news/pharma/moderna-largest-biotech-to-go-public-fails-to-impress-in-market-debut/66996247?utm_source=RSS&utm_medium=ETRSS

Related Posts